Roeland, E., Collins, S. M., Etages-Wong, S. D., Lubaczewski, S. L., Naito, T., Hendifar, A., Fallon, M. T., Takayama, K., Asmis, T. R., Dunne, R. F., Jacobs, I. A., Rossulek, M. I., Qiu, R., Crawford, J., Saxena, A., Groarke, J. (2025). Baseline circulating growth differentiation factor-15 and the cancer phenotype in the PROACC-1 phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.12060